严重程度、关键性和严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）β变异株的致死性。
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant.
机构信息
Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.
World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.
出版信息
Clin Infect Dis. 2022 Aug 24;75(1):e1188-e1191. doi: 10.1093/cid/ciab909.
Beta (B.1.351)-variant coronavirus disease 2019 (COVID-19) disease was investigated in Qatar. Compared with the Alpha (B.1.1.7) variant, odds (95% confidence interval) of progressing to severe disease, critical disease, and COVID-19-related death were 1.24-fold (1.11-1.39), 1.49-fold (1.13-1.97), and 1.57-fold (1.03-2.43) higher, respectively, for the Beta variant.
在卡塔尔对贝塔（B.1.351）变体的 2019 冠状病毒病（COVID-19）进行了研究。与阿尔法（B.1.1.7）变体相比，贝塔变体进展为重症疾病、危重症疾病和 COVID-19 相关死亡的几率（95%置信区间）分别高 1.24 倍（1.11-1.39）、1.49 倍（1.13-1.97）和 1.57 倍（1.03-2.43）。
Zotero 插件